• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group IV report: triggers for developmental neurotoxicity testing.

作者信息

Levine T E, Butcher R E

机构信息

U.S. Environmental Protection Agency, Washington, DC.

出版信息

Neurotoxicol Teratol. 1990 May-Jun;12(3):281-4. doi: 10.1016/0892-0362(90)90100-q.

DOI:10.1016/0892-0362(90)90100-q
PMID:2196426
Abstract

A Work Group was formed to evaluate the criteria considered important in determining when to require developmental neurotoxicity testing in animal studies (i.e., triggers for testing). The primary objective of the Work Group was to determine whether there is sufficient scientific evidence to support the triggers identified by the Environmental Protection Agency and determine whether there is sufficient evidence to use structure activity relationships (SAR) to trigger automatic testing of certain classes of chemicals. A weight of evidence (WOE) approach was recommended by the Work Group in order to assist in determining which agents should undergo developmental neurotoxicity testing and to what level of testing. Evaluation of biological effects, length and duration of exposure, and quality and quantity of data available on an agent should be used in the WOE approach. Agents that are teratogenic to the central nervous system (CNS) were considered of highest priority for developmental neurotoxicity testing, especially if there is the potential for a high degree of exposure. Neuropathic and neuroactive compounds, chemicals with hormone-like activity, and developmental toxicants (with effects other than structural abnormalities of the CNS) were also considered likely candidates for such testing. Although reluctant to recommend testing based solely on SAR or chemical class, the Work Group recognized the importance of considering SAR along with other toxicity data, pharmacokinetic data and potential human exposure in making final requirements or recommendations for further testing.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group IV report: triggers for developmental neurotoxicity testing.
Neurotoxicol Teratol. 1990 May-Jun;12(3):281-4. doi: 10.1016/0892-0362(90)90100-q.
2
Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group II report: testing methods in developmental neurotoxicity for use in human risk assessment.
Neurotoxicol Teratol. 1990 May-Jun;12(3):269-74. doi: 10.1016/0892-0362(90)90098-w.
3
Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity: summary and implications.
Neurotoxicol Teratol. 1990 May-Jun;12(3):285-92. doi: 10.1016/0892-0362(90)90101-h.
4
Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group III report: weight of evidence and quantitative evaluation of developmental neurotoxicity data.
Neurotoxicol Teratol. 1990 May-Jun;12(3):275-80. doi: 10.1016/0892-0362(90)90099-x.
5
Scientific and regulatory issues relevant to assessing risk for developmental neurotoxicity: an overview.
Neurotoxicol Teratol. 1990 May-Jun;12(3):175-81. doi: 10.1016/0892-0362(90)90089-u.
6
Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group I report: comparability of measures of developmental neurotoxicity in humans and laboratory animals.人类与动物发育神经毒性的定性和定量可比性研讨会,第一工作组报告:人类和实验动物发育神经毒性测量方法的可比性
Neurotoxicol Teratol. 1990 May-Jun;12(3):261-7. doi: 10.1016/0892-0362(90)90097-v.
7
A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies.发育神经毒性研究中阳性对照数据的定性回顾性分析。
Neurotoxicol Teratol. 2004 May-Jun;26(3):345-52. doi: 10.1016/j.ntt.2004.02.007.
8
An analysis of the U.S. Environmental Protection Agency neurotoxicity testing guidelines.
Regul Toxicol Pharmacol. 1992 Oct;16(2):202-12. doi: 10.1016/0273-2300(92)90058-h.
9
Qualitative and quantitative comparability of human and animal developmental neurotoxicants: a workshop summary.
Neurotoxicology. 1990 Summer;11(2):257-69.
10
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.转基因植物及其衍生食品和饲料的安全性与营养评估:动物饲养试验的作用
Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13.

引用本文的文献

1
A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426.一项支持经合组织测试指南426的发育神经毒性研究的回顾性性能评估。
Environ Health Perspect. 2009 Jan;117(1):17-25. doi: 10.1289/ehp.11447. Epub 2008 Aug 12.
2
Consensus workshop on methods to evaluate developmental immunotoxicity.发育免疫毒性评估方法共识研讨会
Environ Health Perspect. 2003 Apr;111(4):579-83. doi: 10.1289/ehp.5860.
3
Setting exposure standards: a decision process.设定接触标准:一个决策过程。
Environ Health Perspect. 1996 Apr;104 Suppl 2(Suppl 2):401-5. doi: 10.1289/ehp.96104s2401.